Gao Hanlin 4

What Happened

• Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 945 shares on May 27, 2026. The sales generated approximately $16,632 based on a weighted-average price of $17.60 per share. The filing lists the transaction as an open‑market/private sale (code S) and indicates the sale was to satisfy tax withholding obligations related to vested restricted stock units (RSUs).

Key Details

• Transaction date: 2026-05-27; Form 4 filed: 2026-05-28 (timely filing).
• Prices: multiple transactions at $17.39–$17.76; reported weighted-average sale price $17.60.
• Total proceeds reported: $16,632 (945 shares).
• Reason: Footnote states shares were sold to satisfy tax withholding on RSUs granted 2024-02-26.
• Footnote also notes sales occurred in multiple transactions and the filer can provide detailed per‑trade breakdowns upon request.
• Shares owned after the transaction: not specified in the provided filing.

Context

• This was a sale tied to tax withholding for vested RSUs (routine administrative sale), not necessarily a discretionary market sale expressing sentiment. Sales to cover taxes are common following vesting events and typically do not indicate a change in an insider’s view of the company.